Vasopharm grabs almost $22 mln

By Iris Dorbian — 2 weeks ago

Germany-based Vasopharm, a biopharmaceutical company focused on treating cerebrovascular diseases, has secured 20 million euros (almost $22 million) in funding. Entrepreneurs Fund, Heidelberg Capital Private Equity and Fort Rock Capital led the round. Other investors were Bayern Kapital and funds advised by Hanseatic Asset Management LBG. In addition to the funding, Dr Mario Alberto Accardi, a venture partner at Fort Rock Capital, has been added to Vasopharm’s board of directors.


SmartKem rakes in Series A funds

By Iris Dorbian — 1 year ago

SmartKem has secured “significant” Series A funding. The investors were BASF Venture Capital, Octopus Investments, Entrepreneurs Fund and Finance Wales. Based in the UK, SmartKem is a provider of semiconductor materials.


OptiNose grabs Series C-1 funds

By Iris Dorbian — 2 years ago

OptiNose said Monday that it has received an undisclosed amount of Series C-1 funding. The company’s investors include Avista Capital Partners, WFD Ventures and Entrepreneurs Fund. Headquartered in Yardley, Penn., OptiNose is a specialty pharmaceutical firm that’s built around a nasal delivery platform.


Sequana Medical raises Series C

By Angela Sormani — 2 years ago

Sequana Medical has raised CHF 23 million ($26.2 million) in a Series C preferred share financing round led by Life Science Partners and co-led by NeoMed Management, VI Partners, BioMedInvest, Entrepreneurs Fund and Capricorn Venture Partners. The business is a Swiss medical device company.


CYTOO and Cenix Join Forces

By Angela Sormani — 4 years ago

Grenoble, France-based CYTOO, a a provider of innovative enabling technologies for high content cell analysis, has teamed up with Cenix BioScience, a developer of industrial high-content screening applications of RNAi. CYTOO in November closed of a series C funding round of $10 million. New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors […]


General Fusion Rounds up Nearly $20M in Series B

By Jonathan Marino — 5 years ago

General Fusion is having a happy Cinco de Mayo. The utility-scale fusion power company reeled in $19.5 million in a Series B round that included investors Cenovus Energy, through its Environmental Opportunity Fund, Bezos Expeditions, the personal investment company of Jeff Bezos, Chrysalix Energy Venture Capital, GrowthWorks, Braemar Energy Ventures, Entrepreneurs Fund, Business Development Bank of Canada (BDC), and SET Venture Partners.


NovaShunt Raises $25M in Series B

5 years ago

Swiss medical device start-up NovaShunt AG has raised roughly $25 million in Series B financing. BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund co-led the round, which included participation from existing shareholders NeoMed and VI Partners. NovaShunt is developing an implantable pump system that continually removes excess abdominal fluid in patients suffering from liver cirrhosis, certain cancers and congestive heart failure.